A Study of CS1002 in Subjects with Advanced Solid Tumors
NCT03523819
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
91
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor, Adult
Interventions
DRUG:
CS1002
DRUG:
CS1003
Sponsor
CStone Pharmaceuticals